PASEMNOGENE GLEPARVOVEC CAPSID
UNII F9M4Q9QC7M

Substance Identification & Data

This profile provides standardized clinical and technical data for Pasemnogene Gleparvovec Capsid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F9M4Q9QC7M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
F9M4Q9QC7M
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PASEMNOGENE GLEPARVOVEC CAPSID
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
specifiedSubstanceG1
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pasemnogene Gleparvovec Capsid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CAPSOMERE, RECOMBINANT ADENO-ASSOCIATED VIRUS 9 VIRAL CAPSID PROTEIN VP1 (422-TRYPTOPHAN,446-PHENYLALANINE) COMPLEX WITH VIRAL CAPSID PROTEIN VP2 (285-TRYPTOPHAN,309-PHENYLALANINE) COMPLEX WITH VIRAL CAPSID PROTEIN VP3 (220-TRYPTOPHAN,244-PHENYLALANINE) DECAMER, HEXACONTAMER
PASEMNOGENE GLEPARVOVEC CAPSID

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record